Invasive Lobular Carcinoma (USA)

49 year old lady, no symptoms. In this insight to the views. Who detected some microcalcifications in the left breast? If you move to the turmoil. We can see that the microcalcifications are associated with. A tiny distortion. And in this. It's not compression with turbo. We perfectly can see the microcalcifications and the associated distortion and the tiny mass. Beside the micro facilitations. The correlation with ultrasound was very nice, showing a deeply located small mass. And also the correlation with MRI showing. Mason commencement. The final result was invasive lobular cancer measuring 6 millimeters. So the spot compression with Tomo is a useful tool to assess. Microcalcifications.

1/1/2022 5/4/2021 Characterization 2 Digital Breast Tomosynthesis and Contrast Enhanced Mammography Prof. Dr. Luis Pina Breast Imaging Department (Radiología mamaria) Clínica Universidad de Navarra, Pamplona / Spain SIEMENS . 06_Characterization_2, PID3629 * 1/1/2022 F PID3629 Series Navigator INSIGHT_2D Add Study PID3629 4/1/2021 (Study date) Current MG, 4/1/2021 n.a ., 12 mon ... Mamograffa Bilateral LMLO Viewing Favorite Layouts US MR DYN IN 2D MR.Dyna ... MR.Empty ReportFlow BASI Printing Tools Findings MR 6:18 PM Clinical information 49-year-old female Asymptomatic Healthineers LCC Slice 34 / 63 Slice 24 / 62 Slice thickness: 1.00 mm BASIC N 2D 1/1/2022, F Subtraction check 3:08:47 PM 1977 IMA 47 MR, 4/1/2021 n.a ., 13 month .. L 1.5 mm SP H34.1 Zoom 1.77 CEM bila .. p2 SL INSIGHT_2D_RMLO Slice thigkness: 1.00 mm Pathology Invasive lobular carcinoma (ILC) Luminal A, 6 mm Conclusion Spot DBT is useful to assess microcalcifications in a suspicious lesion. + Siemens Healthcare GmbH, 2022 Sometimes IN2D images (= synthetic mammograms) are shown while verbally referring to the conventional mammograms. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. Results from case studies are not predictive of results in other cases. Results in other cases may vary. The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist (e.g ., hospital size, samples mix, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results. Dr. Luis Pina is employed by an institution that receives financial support from Siemens Healthineers for collaborations. SIEMENS